Dae Seog Heo

Seoul National University Hospital

H指数:77

被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Confusion in Terminology Related to End-of-Life Decisions: Euthanasia, Physician-Assisted Suicide and Decisions on Life-Sustaining Treatment: A Survey of Korean Public

与临终决策相关的术语混淆：安乐死、医生协助自杀和生命维持治疗决策：一项针对韩国公众的调查

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2025-11-100

Association between Tumor Size at the Time of Disease Progression and Survival Outcomes

疾病进展时肿瘤大小与生存结局之间的关联

CANCER RESEARCH AND TREATMENT

IF3.8

2024-10-220

Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-09-011

PRE

The synergistic potential of PARP inhibitors and irinotecan in small cell lung cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma (vol 34, pg 2184, 2020)

LEUKEMIA

IF13.4

2024-01-100

OAAI

Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2023-05-232

PRE

Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute

ANNALS OF HEMATOLOGY

IF2.4

2023-04-260

PRE

Treatment-free remission after discontinuation of ALK tyrosine kinase inhibitors (TKIs) in patients with ALK-positive anaplastic large cell lymphoma (ALCL)

CANCER RESEARCH

IF16.6

2023-04-040

PRE

The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2022-11-2516

PRE

Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis

SCIENTIFIC REPORTS

IF3.9

2022-07-223

OAAI

Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab

接受利妥昔单抗治疗的患者对肺炎肺孢子虫的初级预防

CHEST

IF8.6

2022-05-0126

Hospice-Palliative Medicine as a Model of Value-Based Healthcare

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2022-01-013

OAAI

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

SCIENTIFIC REPORTS

IF3.9

2021-10-0586

OAAI

A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas

HAEMATOLOGICA

IF7.9

2021-04-0117

OAAI

Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma

程序性死亡配体1表达水平作为肺腺癌EGFR酪氨酸激酶抑制剂疗效的预测指标

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2021-02-0114

OAAI

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

SCIENTIFIC REPORTS

IF3.9

2021-01-2825

OAAI

Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells

polo样激酶和pan-raf联合阻断对NRAS突变的非小细胞肺癌细胞有效

CANCER LETTERS

IF10.1

2020-12-0112

OAAI

Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-08-2356

OAAI

Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies

基于下一代测序的面板在BRAF野生型晚期黑色素瘤中的临床应用确定了关键的致癌改变和治疗策略

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-03-0215

PREAI

Dae Seog Heo

个人简介

教育背景

工作经历

荣誉奖项

研究方向